After an unsuccessful percutaneous coronary intervention for chronic total occlusion, subintimal tracking and reentry with ...

ASCVD Risk Estimator Plus and PREVENT calculator would have classified many patients as low risk 48 hours before myocardial infarction.

Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables ...

Nearly half of adults with a first myocardial infarction show low or borderline risk on current risk estimators. Most develop ...

Key points A 56-year-old woman presented to the emergency department with a 2-day history of central chest pain and dyspnea. Her medical history included having had a myocardial infarction (MI) with n ...

PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles ...

A new study published in The American Journal of Cardiology revealed acute total occlusion (ATO) in non-ST-segment elevation ...

Detailed price information for Cardio Diagnostics Hldgs Inc (CDIO-Q) from The Globe and Mail including charting and trades.

The main goal in STEMI is to restore blood flow to reduce myocardial injury, Mehran explained. The novel glycoprotein IIb/IIIa inhibitor locks the receptor in its inactive position, which can reduce ...

Detailed price information for Esperion Theraptc (ESPR-Q) from The Globe and Mail including charting and trades.

Introduction: Post-myocardial infarction ventricular septal defect (MI-VSD) is a rare, often fatal complication of MI, regardless of treatment approach. Presentations vary from new murmurs to acute ...